KLK3 and neoplasm: Lopci et al.25 reported that, for patients with overall PSA level, the ROC analysis demonstrated that a SUVmax > 4.8 could differentiate tumour lesions from benign conditions with a sensitivity of 82.4% and specificity of 72.2% (AUC = 0.843).